News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
CATUG and Crystal Bio Form Strategic Partnership, Introducing 'CATUG-Crystal' Joint Lab Dedicated to Advanced Nucleic Acid Analysis Services
Friday, February 23, 2024CATUG Inc and Crystal Bio a member of Crystal Pharmatech have recently announced a longterm strategic partnership to provide advanced nucleic acidbased drug analytical services CATUG is known for its expertise in integrated nucleic acid and drug deli...
ReAlta Life Sciences Commences Phase 2 Trial of RLS-0071 for Acute Exacerbations of Chronic Obstructive Pulmonary Disease with First Patient Dosing
Thursday, February 22, 2024ReAlta Life Sciences Inc a biotech company specializing in midstage clinical research has initiated enrollment for a Phase clinical trial for RLS This investigational drug developed from ReAltas EPICC
Aleta Biotherapeutics and Cancer Research UK's Centre for Drug Development Initiate First Patient Dosing in ALETA-001 Phase 1/2 Clinical Trial for Relapsed/Refractory B-Cell Malignancies
Thursday, February 22, 2024Aleta Biotherapeutics a company specializing in immunooncology with a focus on CAR TCell Engager platforms to enhance cancer therapies in collaboration with Cancer Research UKs Centre for Drug Development
Avance Clinical and Ryght Collaborate to Introduce Innovative GenAI Technologies in Clinical Research Networks
Wednesday, February 21, 2024Ryght a trailblazer in generative artificial intelligence technology for the life science industry has unveiled a strategic collaboration with Avance Clinical the foremost specialist Australian and US
Charles River Teams Up with Pluristyx to Broaden Human Pluripotent Stem Cell Offerings
Wednesday, February 21, 2024Charles River Laboratories International Inc has recently announced a partnership with Pluristyx Inc a leading provider in the field of tools technologies and services for cell therapy development
BioCryst Unveils ORLADEYO® (berotralstat) in Italy
Tuesday, February 20, 2024BioCryst Pharmaceuticals Inc made an announcement today regarding the decision by the Italian Medicines Agency Agenzia Italiana del Farmaco which has completed the reimbursement process and endorsed ORLADEYO This medication is recommended for the rou...
FDA Accepts Biologics License Application for Datopotamab Deruxtecan in Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
Monday, February 19, 2024Daiichi Sankyo and AstraZenecas Biologics License Application for datopotamab deruxtecan has been accepted in the United States for the treatment of adult patients with locally advanced or metastatic nonsquamous
Sibeprenlimab Granted Breakthrough Therapy Designation by U.S. FDA for Immunoglobulin A Nephropathy
Saturday, February 17, 2024Otsuka Pharmaceutical Development Commercialization Inc alongside Otsuka Pharmaceutical Co Ltd and Visterra Inc a subsidiary of Otsuka have announced that the US Food and Drug Administration
OrphAI Therapeutics Obtains Orphan Drug Designation in the European Union for AIT-101 as a Treatment for Amyotrophic Lateral Sclerosis
Friday, February 16, 2024OrphAI Therapeutics Inc a biopharmaceutical firm focused on developing novel therapies for rare diseases has announced that it has obtained Orphan Drug Designation from the European Union
AMO Pharma and Population Health Research Institute Collaborate on Tideglusib Clinical Trial for Arrhythmogenic Cardiomyopathy Treatment Efficacy Assessment
Friday, February 16, 2024AMO Pharma Limited a leading clinicalstage biopharmaceutical company specializing in rare genetic disorders has announced a groundbreaking collaboration with the Population Health Research Institute
